Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2

Sponsor Class

INDUSTRY 52OTHER 36NIH 3NETWORK 3UNKNOWN 2OTHER_GOV 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 4Stomach Neoplasms 2Neoplasm Metastasis 2Skin Diseases 1Sarcoma 1Neoplasms by Site 1Carcinoma, Ductal, Breast 1Breast Diseases 1Breast Cancer Recurrent 1

Interventions

Capecitabine 3Docetaxel 2titanium silicide 1sintilimab 1Vinorelbine 1Platinum Compounds 1Oxaliplatin 1Irinotecan 1Etoposide 1Drug Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Neoplasm Metastasis × Docetaxel × Clear all
NCT01917279 2020-07-23

CAMELLIA

ChineseAMS

Phase 3 Unknown
280 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡